CCDC134 Antibody (026) [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90189FR
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 026
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human CCDC134 (Uniprot#: Q9H6E4; Met1-Leu229).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for CCDC134 Antibody (026) [DyLight 680]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCDC134
Long Name
Coiled-coil Domain Containing 134
Alternate Names
coiled-coil domain containing 134, coiled-coil domain-containing protein 134, dJ821D11.3, FLJ22349, MGC21013
Gene Symbol
CCDC134
Additional CCDC134 Products
Product Documents for CCDC134 Antibody (026) [DyLight 680]
Product Specific Notices for CCDC134 Antibody (026) [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...